Company: RDPTF
Filing Date: 2025-09-18
Form Type: 20-F
Source: 0001213900-25-088699
Chunk: 35

Company: Radiopharm Theranostics Ltd
Filing Date: 2025-09-18
Form: 20-F
Item: Item 3
Chunk 35
---
 and the waiver would likely not apply to ADS holders or beneficial owners who subsequently
withdraw the ordinary shares represented by ADSs from the ADS facility with respect to claims arising after the withdrawal. However, to
our knowledge, there has been no case law on the applicability of the jury trial waiver to ADS holders or beneficial owners who withdraw
the ordinary shares represented by the ADSs from the ADS facility. Nevertheless, if this jury trial waiver is not permitted by applicable
law, an action could proceed under the terms of the deposit agreement with a jury trial. No condition, stipulation or provision of the
deposit agreement or the ADSs serves as a waiver by any owner or holder of ADSs or by us or the Depositary of compliance with any substantive
provision of the U. S. federal securities laws and the rules and regulations promulgated thereunder.

The exclusive jurisdiction and arbitration
provided for in the deposit agreement may discourage claims or limit the ability of the ADS holders to bring a claim.

The laws of the State of New
York govern the deposit agreement and the ADSs and we have agreed with the depositary that the federal or state courts in the City of
New York shall have exclusive jurisdiction to hear and determine any dispute arising from or in connection with the deposit agreement
and that the depositary will have the right to refer any claim or dispute arising from the relationship created by the deposit agreement
to arbitration in accordance with the Commercial Arbitration Rules of the American Arbitration Association. The arbitration provision
of the deposit agreement does not preclude ADS holders from pursuing claims under the Securities Act or the Exchange Act in federal courts.
In addition, the arbitration provision does not preclude ADS holders from pursuing Securities Act or Exchange Act claims against Radiopharm
or the Depositary in state courts.

In addition, any legal suit,
action or proceeding, including claims under the Securities Act or the Exchange Act, against or involving Radiopharm or the Depositary
that arise out of or are based upon the Deposit Agreement, ownership of the ADSs or the transactions contemplated by the deposit agreement
(including any such action or proceeding which may arise under the Securities Act or Exchange Act) may only be instituted by holders of
ADSs, including purchasers of ADSs in secondary transactions, in a state or federal court in the City of New York. Holders of ADSs irrevocably
waive any objection which they may have to the laying of venue of any such proceeding, and irrevocably submit to the exclusive